Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 22460239)

1.

A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteers.

Venkatakrishnan K, Kramer WG, Synold TW, Goodman DB, Sides E 3rd, Oliva C.

Eur J Clin Pharmacol. 2012 Oct;68(10):1347-55. doi: 10.1007/s00228-012-1262-1. Epub 2012 Mar 30.

PMID:
22460239
2.

Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment.

Venkatakrishnan K, Liu Y, Noe D, Mertz J, Bargfrede M, Marbury T, Farbakhsh K, Oliva C, Milton A.

Br J Clin Pharmacol. 2014 Jun;77(6):986-97. doi: 10.1111/bcp.12260.

3.

Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate hepatic impairment.

Venkatakrishnan K, Liu Y, Noe D, Mertz J, Bargfrede M, Marbury T, Farbakhsh K, Oliva C, Milton A.

Br J Clin Pharmacol. 2014 Jun;77(6):998-1010. doi: 10.1111/bcp.12261.

4.

Combination therapy with ifosfamide and liposome-encapsulated muramyl tripeptide: tolerability, toxicity, and immune stimulation.

Kleinerman ES, Meyers PA, Raymond AK, Gano JB, Jia SF, Jaffe N.

J Immunother Emphasis Tumor Immunol. 1995 Apr;17(3):181-93.

PMID:
7613644
5.

Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.

Anderson PM, Meyers P, Kleinerman E, Venkatakrishnan K, Hughes DP, Herzog C, Huh W, Sutphin R, Vyas YM, Shen V, Warwick A, Yeager N, Oliva C, Wang B, Liu Y, Chou A.

Pediatr Blood Cancer. 2014 Feb;61(2):238-44. doi: 10.1002/pbc.24686. Epub 2013 Aug 31.

PMID:
23997016
6.

Anti-(tumor necrosis factor) alters the response of human monocytes to liposomal muramyl tripeptide.

Maeda M, Asano T, Kleinerman ES.

Cancer Immunol Immunother. 1993 Aug;37(3):203-8.

PMID:
8334682
7.
8.

Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients.

Murray JL, Kleinerman ES, Cunningham JE, Tatom JR, Andrejcio K, Lepe-Zuniga J, Lamki LM, Rosenblum MG, Frost H, Gutterman JU, et al.

J Clin Oncol. 1989 Dec;7(12):1915-25.

PMID:
2479721
10.

Pharmacokinetics and immunomodulatory effects on monocytes during prolonged therapy with liposomal muramyltripeptide.

Landmann R, Obrist R, Denz H, Ludwig C, Frost H, Wesp M, Rordorf C, Towbin H, Gygax D, Tarcsay L, et al.

Biotherapy. 1993;7(1):1-12.

PMID:
8068481
11.

Comparative pharmacokinetics of free muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) and liposomal MTP-PE.

Gay B, Cardot JM, Schnell C, van Hoogevest P, Gygax D.

J Pharm Sci. 1993 Oct;82(10):997-1001.

PMID:
8254500
12.

Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.

Kleinerman ES, Jia SF, Griffin J, Seibel NL, Benjamin RS, Jaffe N.

J Clin Oncol. 1992 Aug;10(8):1310-6.

PMID:
1634921
14.

Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.

Kleinerman ES, Gano JB, Johnston DA, Benjamin RS, Jaffe N.

Am J Clin Oncol. 1995 Apr;18(2):93-9.

PMID:
7900714
15.
16.

Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanoma.

Liebes L, Walsh CM, Chachoua A, Oratz R, Richards D, Hochster H, Peace D, Marino D, Alba S, Le Sher D, et al.

J Natl Cancer Inst. 1992 May 6;84(9):694-9.

PMID:
1569602
17.

Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy.

Asano T, Kleinerman ES.

J Immunother Emphasis Tumor Immunol. 1993 Nov;14(4):286-92.

PMID:
8280710
19.

Soluble intercellular adhesion molecule-1 and serum cytokines in melanoma patients treated with liposomes containing muramyl tripeptide.

Favaro D, Santarosa M, Quaia M, Spada A, Freschi A, Talamini R, Galligioni E.

Tumori. 1995 May-Jun;81(3):185-90.

PMID:
7571025
20.

Cytokine production and immune cell activation in melanoma patients treated with liposomal muramyl tripeptide (CGP 19835A lipid).

Fujimaki W, Itoh K, An T, Gano JB, Ross MI, Mansfield PF, Balch CM, Augustus LB, Karkevitch DD, Johnston D, et al.

Cancer Biother. 1993 Winter;8(4):307-18.

PMID:
7804372
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk